Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: Propensity score analysis of a territory-wide cohort in Hong Kong
Version 2 2024-06-02, 23:00Version 2 2024-06-02, 23:00
Version 1 2023-07-18, 03:48Version 1 2023-07-18, 03:48
journal contribution
posted on 2024-06-02, 23:00authored byCKH Wong, DTW Lui, AYC Lui, ACY Kwok, MCH Low, KTK Lau, ICH Au, X Xiong, MSH Chung, Eric LauEric Lau, BJ Cowling
Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: Propensity score analysis of a territory-wide cohort in Hong Kong